ANNEX IIF1LIST OF SUBSTANCES WHICH MUST NOT FORM PART OF THE COMPOSITION OF COSMETIC PRODUCTS
Inserted by Council Directive of 17 May 1982 (82/368/EEC).
Deleted by Commission Directive of 20 February 1990 (90/121/EEC).
Inserted by Commission Directive of 30 March 1983 (83/191/EEC).
Inserted by Commission Directive of 16 July 1985 (85/391/EEC).
Inserted by Commission Directive of 26 March 1986 (86/199/EEC).
Inserted by Commission Directive of 12 March 1991 (91/184/EEC).
Deleted by Commission Directive of 21 February 1989 (89/174/EEC).
Inserted by Commission Directive of 20 February 1990 (90/121/EEC).
Inserted by Commission Directive of 18 July 1984 (84/415/EEC).
Deleted by Commission Directive of 2 March 1988 (88/233/EEC).
Inserted by Commission Directive of 10 July 1995 (95/34/EC).
Inserted by Commission Directive of 29 June 1983 (83/341/EEC).
Inserted by Commission Directive of 28 February 1986 (86/179/EEC).
Inserted by Commission Directive of 2 February 1987 (87/137/EEC).
Inserted by Commission Directive of 2 March 1988 (88/233/EEC).
Inserted by Commission Directive of 21 February 1989 (89/174/EEC).
Inserted by Commission Directive of 21 October 1992 (92/86/EEC).
Inserted by Commission Directive of 22 June 1993 (93/47/EEC).
Inserted by Commission Directive of 29 June 1994 (94/32/EC).
Deleted by Commission Directive of 14 July 1997 (97/45/EC).
Inserted by Commission Directive of 25 June 1996 (96/41/EC).
Inserted by Commission Directive of 5 March 1998 (98/16/EC).
Inserted by Commission Directive of 14 July 1997 (97/45/EC).
Inserted by Commission Directive of 3 September 1998 (98/62/EC).
- 1.
N-5-Chlorobenzoxazol-2-ylacetamide
- 2.
F12-Acetoxyethyltrimethylammonium hydroxide (acetylcholine) and its salts
- 3.
Deanol aceglumate7
- 4.
Spironolactone*
- 5.
F1[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts
- 6.
Methotrexate*
- 7.
Aminocaproic acid* and its salts
- 8.
Cinchophen*, its salts, derivatives and salts of these derivatives
- 9.
Thyropropic acid* and its salts
- 10.
Trichloroacetic acid
- 11.
Aconitum napellus L. (leaves, roots and galenical preparations)
- 12.
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts
- 13.
Adonis vernalis L. and its preparations
- 14.
Epinephrine*
- 15.
Rauwolfia serpentina alkaloids and their salts
- 16.
Alkyne alcohols, their esters, ethers and salts
- 17.
Isoprenaline*
- 18.
Allyl isothiocyanate
- 19.
Alloclamide* and its salts
- 20.
Nalorphine*, its salts and ethers
- 21.
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe
- 22.
Aniline, its salts and its halogenated and sulphonated derivatives
- 23.
Betoxycaine* and its salts
- 24.
Zoxazolamine*
- 25.
Procainamide*, its salts and derivatives
- 26.
Benzidine
- 27.
Tuaminoheptane*, its isomers and salts
- 28.
Octodrine* and its salts
- 29.
F12-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts
- 30.
1,3-dimethylpentylamine and its salts
- 31.
4-Aminosalicylic acid and its salts
- 32.
Toluidines, their isomers, salts and halogenated and sulphonated derivatives
- 33.
Xylidines, their isomers, salts and halogenated and sulphonated derivatives
- 34.
F1Imperatorin (9-(3-methoxylbut-2-enyloxy)furo[3,2-g]chromen-7-one)
- 35.
Ammi majus and its galenical preparations
- 36.
2,3-Dichloro-2-methylbutane
- 37.
Substances with androgenic effect
- 38.
Anthracene oil
- 39.
Antibiotics
F2 - 40.
Antimony and its compounds
- 41.
Apocynum cannabinum L. and its preparations
- 42.
F1Apomorphine (R 5,6,6a, 7-tetrahydro-6-methyl-4H-dibenzo [de,g]quinoline-10,11-diol) and its salts
- 43.
Arsenic and its compounds
- 44.
Atropa belladonna L. and its preparations
- 45.
Atropine, its salts and derivatives
- 46.
F3Barium salts, with the exception of barium sulphate, barium sulphide under the conditions laid down in Annex III, Part 1, and lakes, salts and pigments prepared from the colouring agents listed with the reference (5) in Annex III, Part 2 and Annex IV, Part 2.
- 47.
Benzene
- 48.
F1Benzimidazol-2(3H)-one
- 49.
F1Benzazepines and benzodiazepines
- 50.
F11-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts
- 51.
F12,2,6-Trimethyl-4-piperidyl benzoate (benzamine) and its salts
- 52.
F1Isocarboxazid*
- 53.
Bendroflumethiazide* and its derivatives
- 54.
Beryllium and its compounds
- 55.
Bromine, elemental
- 56.
Bretylium tosilate*
- 57.
Carbromal*
- 58.
Bromisoval*
- 59.
Brompheniramine* and its salts
- 60.
Benzilonium bromide*
- 61.
Tetrylammonium bromide*
- 62.
Brucine
- 63.
Tetracaine* and its salts
- 64.
Mofebutazone*
- 65.
Tolbutamide*
- 66.
Carbutamide*
- 67.
Phenylbutazone*
- 68.
Cadmium and its compounds
- 69.
Cantharides, Cantharis vesicatoria
- 70.
(1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride (cantharidin)
- 71.
Phenprobamate*
- 72.
F1Nitroderivatives of carbazole
- 73.
Carbon disulphide
- 74.
Catalase
- 75.
Cephaeline and its salts
- 76.
Chenopodium ambrosioides (essential oil)
- 77.
2,2,2-Trichloroethane-1,1-diol
- 78.
Chlorine
- 79.
Chlorpropamide*
- 80.
F1Diphenoxylate* hydrochloride
- 81.
4-Phenylazophenylene-1,3-diamine citrate hydrochloride (chrysoidine citrate hydrochloride)
- 82.
Chlorzoxazone*
- 83.
2-Chloro-6-methylpyrimidin-4-yldimethylamine (crimidine-ISO)
- 84.
Chlorprothixene* and its salts
- 85.
Clofenamide*
- 86.
F1N,N-bis(2-chloroethyl)methylamine N-oxide and its salts
- 87.
Chlormethine* and its salts
- 88.
Cyclophosphamide* and its salts
- 89.
Mannomustine* and its salts
- 90.
Butanilicaine* and its salts
- 91.
F1Chlormezanone*
- 92.
Triparanol*
- 93.
2-[2(4-Chiorophenyl)-2-phenylacetyl] indane-1,3-dione (chlorophacinone-ISO)
- 94.
Chlorphenoxamine*
- 95.
F12-[2-(4-Chlorophenyl)-2-phenylacetyl]indan 1,3-dione (chlorophacinone - ISO)
- 96.
Chloroethane
- 97.
Chromium; chromic acid and its salts
- 98.
Claviceps purpurea Tul., its alkaloids and galenical preparations
- 99.
Conium maculatum L. (fruit, powder, galenical preparations)
- 100.
Glycyclamide*
- 101.
Cobalt benzenesulphonate
- 102.
Colchicine, its salts and derivatives
- 103.
Colchicoside and its derivatives
- 104.
Golchicum autumnale L. and its galenical preparations
- 105.
Convallatoxin
- 106.
Anamirta cocculus L. (fruit)
- 107.
Croton tiglium (oil)
- 108.
1-Butyl-3-(N-crotonoylsulphanilyl)urea
- 109.
Curare and curarine
- 110.
Synthetic curarizants
- 111.
Hydrogen cyanide and its salts
- 112.
F12-α-Cyclohexylbenzyl(N,N,N',N',-tetraethyl)trimethylenediamine (phenetamine)
- 113.
Cyclomenol* and its salts
- 114.
Sodium hexacyclonate*
- 115.
Hexapropymate*
- 116.
Dextropropoxyphene*
- 117.
F1O,O'-Diacetyl-N-allyl-N-normorphine
- 118.
Pipazetate* and its salts
- 119.
F15-(αβ-Dibromophenethyl)-5-methylhydantoin
- 120.
F1N,N'-Pentamethylenebis (trimethylammonium salts), e.g. pentamethonium bromide*
- 121.
F1N,N'-[(Methylimino)diethylene]bis(ethyldimethylammonium) salts, e.g. azamethonium bromide*
- 122.
Cyclarbamate*
- 123.
Clofenotane*; DDT (ISO)
- 124.
F1N,N'-Hexamethylenebis(trimethylammonium) salts, e.g. hexamethonium bromide*
- 125.
Dichloroethanes (ethylene chlorides)
- 126.
Dichloroethylenes (acetylene chlorides)
- 127.
Lysergide* and its salts
- 128.
F12-Diethylaminoethyl-3-hydroxy-4-phenylbenzoate and its salts
- 129.
Cinchocaine* and its salts
- 130.
3-Diethylaminopropyl cinnamate
- 131.
F1O,O'-Diethyl O-4-nitrophenyl phosphorothioate (parathion-lSO)
- 132.
F1[Oxalylbisiminoethylene)]bis[(o-chlorobenzyl)diethylammonium salts], e.g. ambenomium cloride*
- 133.
Methyprylon* and its salts
- 134.
Digitaline and all heterosides of Digitalis purpurea L.
- 135.
7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline (xanthinol)
- 136.
Dioxethedrin* and its salts
- 137.
Piprocurarium*
- 138.
Propyphenazone*
- 139.
Tetrabenazine* and its salts
- 140.
Captodiame*
- 141.
Mefeclorazine* and its salts
- 142.
Dimethylamine
- 143.
F11,1-Bis(dimethylaminomethyl)propyl benzoate (amydricaine, alypine) and its salts
- 144.
Methapyrilene* and its salts
- 145.
Metamfepramone* and its salts
- 146.
Amitriptyline* and its salts
- 147.
Metformin* and its salts
- 148.
Isosorbide dinitrate*
- 149.
Malononitrile
- 150.
Succinonitrile
- 151.
Dinitrophenol isomers
- 152.
Inproquone*
- 153.
Dimevamide* and its salts
- 154.
Diphenylpyraline* and its salts
- 155.
Sulfinpyrazone*
- 156.
F1N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethyl-ammonium salts, e.g. isopropamide iodide*
- 157.
Benactyzine*
- 158.
Benzatropine* and its salts
- 159.
Cyclizine* and its salts
- 160.
F15,5-Diphenyl-4-imidazolidone
- 161.
Probenecid*
- 162.
Disulfiram*; thiram (ISO)
- 163.
Emetine, its salts and derivatives
- 164.
Ephedrine and its salts
- 165.
Oxanamide* and its derivatives
- 166.
Eserine or physostigmine and its salts
- 167.
Esters of 4-aminobenzoic acid, with the free amino group, with the exception of that given in F4Annex VII, Part 2
- 168.
Choline salts and their esters, e.g. choline chloride
- 169.
Caramiphen* and its salts
- 170.
Diethyl 4-nitrophenyl phosphate
- 171.
Metethoheptazine* and its salts
- 172.
Oxpheneridine* and its salts
- 173.
Ethoheptazine* and its salts
- 174.
Metheptazine* and its salts
- 175.
Methylphenidate* and its salts
- 176.
Doxylamine* and its salts
- 177.
Tolboxane*
- 178.
- 179.
Parethoxycaine* and its salts
- 180.
Fenozolone*
- 181.
Glutethimide* and its salts
- 182.
Ethylene oxide
- 183.
Bemegride* and its salts
- 184.
Valnoctamide*
- 185.
Haloperidol*
- 186.
Paramethasone*
- 187.
Fluanisone*
- 188.
Trifluperidol*
- 189.
Fluoresone*
- 190.
Fluorouracil*
- 191.
F1Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with the exception of those given in Annex III, Part 1
- 192.
Furfuryltrimethylammonium salts, e.g. furtrethonium iodide*
- 193.
Galantamine*
- 194.
Progestogens
F2 - 195.
1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)
- 196.
F1(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethano-naphthalene (endrin-ISO)
- 197.
Hexachloroethane
- 198.
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethano-naphthalene (isodrin-ISO)
- 199.
Hydrastine, hydrastinine and their salts
- 200.
Hydrazides and their salts
- 201.
Hydrazine, its derivatives and their salts
- 202.
Octamoxin* and its salts
- 203.
Warfarin* and its salts
- 204.
F1Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl) acetate and salts of the acid
- 205.
Methocarbamol*
- 206.
Propatylnitrate*
- 207.
F14,4'-Dihydroxy-3,3'-(3-methylthiopropylidene) dicoumarin
- 208.
Fenadiazole*
- 209.
Nitroxoline* and its salts
- 210.
Hyoscyamine, its salts and derivatives
- 211.
Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations)
- 212.
Pemoline* and its salts
- 213.
Iodine
- 214.
F1Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide
- 215.
Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations)
- 216.
(2-Isopropylpent.4-enoyl)urea (apronalide)
- 217.
F1α-Santonin [(3S,5aR,9bS)-3,3a,4,5,5a,9b-hexahydro-3,5a,9-trimethylnaphto [1,2-b] furan-2,8-dione]
- 218.
Lobelia inflata L. and its galenical preparations
- 219.
Lobeline* and its salts
- 220.
Barbiturates
- 221.
F6Mercury and its compounds, except those special cases included F7in Annex VI, Part 1
- 222.
3,4,5-Trimethoxyphenethylamine and its salts
- 223.
Metaldehyde
- 224.
2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts
- 225.
Coumetarol*
- 226.
Dextromethorphan* and its salts
- 227.
2-Methylheptylamine and its salts
- 228.
Isometheptene* and its salts
- 229.
Mecamylamine*
- 230.
Guaifenesin*
- 231.
Dicoumarol*
- 232.
Phenmetrazine*, its derivatives and salts
- 233.
Thiamazole*
- 234.
F13,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano [3,2-c]-[1] benzopyran-5-one (cyclocoumarol)
- 235.
Carisoprodol*
- 236.
Meprobamate*
- 237.
Tefazoline* and its salts
- 238.
Arecoline
- 239.
Poldine metilsulfate*
- 240.
Hydroxyzine*
- 241.
2-Naphthol
- 242.
1-and 2-Naphthylamines and their salts
- 243.
F13-(1-Naphthyl)-4-hydroxycoumarin
- 244.
Naphazoline* and its salts
- 245.
Neostigmine and its salts (e.g. neostigmine bromide*)
- 246.
Nicotine and its salts
- 247.
Amyl nitrites
- 248.
Inorganic nitrites, with the exception of sodium nitrite
- 249.
Nitrobenzene
- 250.
Nitrocresols and their alkali metal salts
- 251.
Nitrofurantoin*
- 252.
Furazolidone*
- 253.
Propane-1,2,3-triyl trinitrate
- 254.
Acenocoumarol*
- 255.
Alkali pentacyanonitrosylferrate (2-)
- 256.
Nitrostilbenes, their homologues and their derivatives
- 257.
Noradrenaline and its salts
- 258.
Noscapine* and its salts
- 159.
Guanethidine* and its salts
- 260.
Oestrogens
F8 - 261.
Oleandrin
- 262.
Chlortalidone*
- 263.
Pelletierine and its salts
- 264.
Pentachloroethane
- 265.
Pentaerithrityl tetranitrate*
- 266.
Petrichloral*
- 267.
Octamylamine* and its salts
- 268.
F1Picric acid
- 269.
Phenacemide*
- 270.
Difendoxazine*
- 271.
F12-Phenylindan-1,3-dione (phenindione)
- 272.
Ethylphenacemide*
- 273.
Phenprocoumon*
- 274.
Fenyramidol*
- 275.
Triamterene* and its salts
- 276.
F1Tetraethyl pyrophosphate; TEPP (ISO)
- 277.
Tritolyl phosphate
- 278.
Psilocybine*
- 279.
Phosphorus and metal phosphides
- 280.
Thalidomide* and its salts
- 281.
Physostigma venenosum Balf.
- 282.
Picrotoxin
- 283.
Pilocarpine and its salts
- 284.
F1α-Piperidin-2-ylbenzyl acette (SIC! acetate) laevorotatory threoform (levophacetoperane) and its salts
- 285.
Pipradrol* and its salts
- 286.
Azacyclonol* and its salts
- 287.
Bietamiverine*
- 288.
Butopiprine* and its salts
- 289.
Lead and its F9compounds, with the exception of that mentioned in Annex III, No 55 under the conditions stated
- 290.
Coniine
- 291.
Prunus laurocerasus L. (‘cherry laurel water’)
- 292.
Metyrapone*
- 293.
F10Radioactive substances, as defined by Directive 96/29/Euratom8 laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation.
- 294.
Juniperus sabina L. (leaves, essential oil and galenical preparations)
- 295.
Hyoscine, its salts and derivatives
- 296.
Gold salts
- 297.
F4Selenium and its compounds with the exception of selenium disulphiele under the conditions set out under reference No 49 in Annex Ill, Part 1
- 298.
Solanum nigrum L. and its galenical preparations
- 299.
Sparteine and its salts
- 300.
Glucocorticoids
- 301.
Datura stramonium L. and its galenical preparations
- 302.
Strophantines, their aglucones and their respective derivatives
- 303.
Strophantus species and their galenical preparations
- 304.
Strychnine and its salts
- 305.
Strychnos species and their galenical preparations
- 306.
Narcotics, natural and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs signed in New York on 30 March 1961
- 307.
F1Sulphonamides (sulphanilamide and its derivatives…) and their salts obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts
- 308.
Sultiame*
- 309.
Neodymium and its salts
- 310.
Thiotepa*
- 311.
Pilocarpus jaborandi Holmes and its galenical preparations
- 312.
Tellurium and its compounds
- 313.
F1Xylometazoline* and its salts
- 314.
Tetrachloroethylene
- 315.
Carbon tetrachloride
- 316.
Hexaethyl tetraphosphate
- 317.
Thallium and its compounds
- 318.
Thevetia neriifolia Juss., glycoside extract
- 319.
Ethionamide*
- 320.
Phenothiazine* and its compounds
- 321.
F1Thiourea and its derivatives, with the exception of the one listed in Annex III, Part 1
- 322.
Mephenesin* and its esters
- 323.
Vaccines, toxins or serums listed in the Annex to the second Council Directive of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (OJ No L 147, 9. 6. 1975, p. 13)
- 324.
Tranylcypromine* and its salts
- 325.
Trichloronitromethane (chloropicrine)
- 326.
2,2,2-Tribromoethanol (tribromoethyl alcohol)
- 327.
Trichiormethine* and its salts
- 328.
Tretamine*
- 329.
Gallamine triethiodide*
- 330.
Urginea scilla Stern. and its galenical preparations
- 331.
Veratrine, its salts and galenical preparations
- 332.
Schoenocaulon olficinale Lind. (seeds and galenical preparations)
- 333.
F11Veratrum Spp. and their preparations
- 334.
Vinyl chloride monomer
- 335.
Ergocalciferol* and cholecalciferol (vitamins D2 and D3)
- 336.
Salts of O-alkyldithiocarbonic acids
- 337.
Yobimbine and its salts
- 338.
Dimethyl sulfoxide*
- 339.
Diphenhydramine* and its salts
- 340.
4-tert-Butylphenol
- 341.
4-tert-Butylpyrocatechol
- 342.
Dihydrotachysterol
- 343.
Dioxane
- 344.
Morpholine and its salts
- 345.
Pyretbrum album L. and its galenical preparations
- 346.
F12-[4-Methoxybenzyl-N-(2-pyridyl)amino]ethyldimethylamine maleate
- 347.
Tripelennamine*
- 348.
Tetrachlorosalicylanilides
- 349.
Dichlorosalicylanilides
- 350.
- 351.
Dibromosalicylanilides
F12 - 352.
Bithionol*
- 353.
Thiuram monosulphides
- 354.
Thiuram disulphides
- 355.
Dimethylformamide
- 356.
4-Phenylbut-3-en-2-one
- 357.
Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol except for normal content in natural essences used
- 358.
F13Furocoumarines (e.g. trioxysalan*, 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used.
In sun protection and in bronzing products, furocoumarines shall be below 1 mg/kg.
- 359.
Oil from the seeds of Laurus nobilis L.
- 360.
F1Safrole except for normal content in the natural essences used and provided the concentration does not exceed:
100 ppm in the finished product,
50 ppm in products for dental and oral hygiene, and provided that Safrole is not present in toothpastes intended specifically for children
- 361.
5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite
- 362.
F14. . . . . - 362.
F153'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone or 7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphtalen
- 363.
F16O-phenylenediamine and its salts
- 364.
4-methyl-m-phenylenediamine and its salts.
- 365.
F14. . . . . - 365.
F15Aristolochic acid and its salts; Aristolochia spp. and their preparations
- 366.
F17Chloroform
- 367.
F14. . . . . - 367.
F152,3,7,8-Tetra chlorodibenzo-p-dioxin
- 368.
2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane)
- 369.
Pyrithione sodium (INNM)
- 370.
F18N-(Trichloromethylthio)-4-cyclohexene-1,2-dicarboximide (captan)
- 371.
2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane (hexachlorophene)
- 372.
F14. . . . . - 373.
F14. . . . . - 374.
. . . . . - 372.
F19F156-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide (minoxidil) and its salts
- 373.
3,4',5-Tribromosalicylanilide
- 374.
Phytolacca spp. and their preparations
- 375.
Tretinoin (retinoic acid and its salts)
- 376.
1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole - CI 76050) F9and their salts
- 377.
1-Methoxy-2,5-diaminobenzene (2,5-diaminoanisole) F9and their salts
- 378.
Colouring agent CI 12140
- 379.
Colouring agent CI 26105
- 380.
Colouring agent CI 42555
Colouring agent CI 42555-1
Colouring agent CI 42555-2
- 381.
F20Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN))
- 382.
F21. . . . . - 383.
2-Amino.4-nitrophenol
- 384.
2-Amino-5-nitrophenol
- 385.
F911 α-Hydroxypregn-4-ene-3,20-dione and its esters
- 385.
F1511α-Hydroxypregn-4-ene-3, 20-dione) and its esters
- 386.
F14. . . . . - 386.
F15Colouring agent C.I. 42 640
- 387.
Colouring agent CI 13 065
- 388.
Colouring agent CI 42 535
- 389.
Colouring agent CI 61 554
- 390.
F14. . . . . - 391.
. . . . . - 392.
. . . . . - 393.
. . . . . - 394.
. . . . . - 390.
F15Anti-androgens of steroidal structure
- 391.
Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Annex III, Part One, and the zirconium lakes, pigments or salts of the colouring agents listed in Annex IV, Part One, with reference number 3
- 393.
Acetonitrile
- 394.
Tetrahydrozoline and its salts
- 395.
F7Hydroxy-8-quinoline and its sulphate, except for the uses provided for in No 51 in Annex III, Part 1
- 396.
Dithio-2,2-bispyridine-dioxide 1,1' (additive with trihydrated magnesium sulphate) - (pyrithione disulphide + magnesium sulphate)
- 397.
Colouring agent CI 12075 and its lakes, pigments and salts
- 398.
Colouring agent CI 45170 and CI 45170:1
- 399.
Lidocaine
- 400.
F221,2-epoxybutane
- 401.
Colouring agent CI 15585
- 402.
Strontium lactate
- 403.
Strontium nitrate
- 404.
Strontium polycarboxylate
- 405.
Pramocaine
- 406.
4-ethoxy-m-phenylenediamine and its salts
- 407.
2,4-diaminophenylethanol and its salts
- 408.
Catechol
- 409.
Pyrogallol
- 410.
Nitrosamines
- 411.
F5Secondary alkyl- and alkanolamines and their salts
- 412.
F234-Amino-2-nitrophenol
- 413.
F242-Methyl-m-phenylenediamine
- 414.
F134-tert-Butyl-3-methoxy-2,6-dinitrotoluene (Musk Ambrette)
- 427
F25. . . . . - 416.
F13Cells, tissues or products of human origin
- 417.
3,3-Bis(4-hydroxyphenyl)phthalide (Phenolphthalein*)
- 418.
F263-Imidazol-4-ylacrylic acid and its ethyl ester (urocanic acid)
- 419.
F27F28From the date referred to in Article 22(1) of Regulation (EC) No 999/2001 of the European Parliament and of the Council9, the specified risk materials as designated in Annex V to that Regulation, and ingredients derived therefrom.
Until that date, the specified risk materials as designated in Annex XI Part A to Regulation (EC) No 999/2001, and ingredients derived therefrom.
However, tallow derivatives may be used provided that the following methods have been used and strictly certified by the producer:
F29Transesterification or hydrolysis at at least 200 °C and at an appropriate corresponding pressure, for 20 minutes (glycerol, fatty acids and fatty acid esters),
Saponification with NaOH 12M (glycerol and soap):
Batch process: at 95 °C for three hours
or
Continuous process: at 140 °C, two bars (2 000 hPa) for eight minutes or equivalent conditions.
- 420.
F30Crude and refined coal tars
- 421.
F311,1,3,3,5,-Pentamethyl-4,6-dinitroindane (moskene)
- 422.
5-tert-Butyl-1,2,3-trimethyl-4,6-dinitrobenzene (musk tibetene).
- 423.
F32Alanroot oil (Inula helenium) (CAS No 97676-35-2), when used as a fragrance ingredient.
- 424.
Benzyl cyanide (CAS No 140-29-4), when used as a fragrance ingredient.
- 425.
Cyclamen alcohol (CAS No 4756-19-8), when used as a fragrance ingredient.
- 426.
Diethyl maleate (CAS No 141-05-9), when used as a fragrance ingredient.
- 427.
Dihydrocoumarine (CAS No 119-84-6), when used as a fragrance ingredient.
- 428.
2,4-Dihydroxy-3-methylbenzaldehyde (CAS No 6248-20-0), when used as a fragrance ingredient.
- 429.
3,7-Dimethyl-2-octen-1-ol (6,7-Dihydrogeraniol) (CAS No 40607-48-5), when used as a fragrance ingredient.
- 430.
4,6-Dimethyl-8-tert-butylcoumarin (CAS No 17874-34-9), when used as a fragrance ingredient.
- 431.
Dimethyl citraconate (CAS No 617-54-9), when used as a fragrance ingredient.
- 432.
7,11-Dimethyl-4,6,10-dodecatrien-3-one (CAS No 26651-96-7), when used as a fragrance ingredient.
- 433.
6,10-Dimethyl-3,5,9-undecatrien-2-one (CAS No 141-10-6), when used as a fragrance ingredient.
- 434.
Diphenylamine (CAS No 122-39-4), when used as a fragrance ingredient.
- 435.
Ethyl acrylate (CAS No 140-88-5), when used as a fragrance ingredient.
- 436.
Fig leaf absolute (Ficus carica) (CAS No 68916-52-9), when used as a fragrance ingredient.
- 437.
trans-2-Heptenal (CAS No 18829-55-5), when used as a fragrance ingredient.
- 438.
trans-2-Hexenal diethyl acetal (CAS No 67746-30-9), when used as a fragrance ingredient.
- 439.
trans-2-Hexenal dimethyl acetal (CAS No 18318-83-7), when used as a fragrance ingredient.
- 440.
Hydroabietyl alcohol (CAS No 13393-93-6), when used as a fragrance ingredient.
- 441.
6-Isopropyl-2-decahydronaphthalenol (CAS No 34131-99-2), when used as a fragrance ingredient.
- 442.
7-Methoxycoumarin (CAS No 531-59-9), when used as a fragrance ingredient.
- 443.
4-(4-Methoxyphenyl)-3-butene-2-one (CAS No 943-88-4), when used as a fragrance ingredient.
- 444.
1-(4-Methoxyphenyl)-1-penten-3-one (CAS No 104-27-8), when used as a fragrance ingredient.
- 445.
Methyl trans-2-butenoate (CAS No 623-43-8), when used as a fragrance ingredient.
- 446.
7-Methylcoumarin (CAS No 2445-83-2), when used as a fragrance ingredient.
- 447.
5-Methyl-2,3-hexanedione (CAS No 13706-86-0), when used as a fragrance ingredient.
- 448.
2-Pentylidenecyclohexanone (CAS No 25677-40-1), when used as a fragrance ingredient.
- 449.
3,6,10-Trimethyl-3,5,9-undecatrien-2-one (CAS No 1117-41-5), when used as a fragrance ingredient.
- 450.
Verbena oil (Lippia citriodora Kunth.) (CAS No 8024-12-2), when used as a fragrance ingredient.
- 451.
X2Methyleugenol (CAS No 93-15-2) except for normal content in the natural essences used and provided that the concentration does not exceed:
- (a)
0,01 % in fine fragrance
- (b)
0,004 % in eau de toilette
- (c)
0,002 % in fragrance cream
- (d)
0,001 % in rinse-off products
- (e)
0,0002 % in other leave-on products and oral hygiene products.
- (a)
Substituted by Corrigendum to Commission Directive 2003/83/EC of 24 September 2003 adapting to technical progress Annexes II, III and VI to Council Directive 76/768/EEC on the approximation of the laws of Member States relating to cosmetic products (Official Journal of the European Union L 238 of 25 September 2003).